Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Part of paid clinical trials in New Brighton, Minnesota.

Sponsor
Center for International Blood and Marrow Transplant Research
Study ID
NCT04920474
Status
Recruiting

Conditions

  • Allogeneic Stem Cell Transplantation
  • Autologous Stem Cell Transplantation
  • Cellular Therapy
  • Marrow Toxic Injury

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may request access to research samples contained in the Research Sample Repository for the purpose of conducting research including: * investigating molecular explanations for histocompatibility or clinical outcomes through analysis of genomic, epigenetic, or other biomolecular data * evaluating the factors that affect transplant or cellular therapy outcome * studying the distribution of HLA tissue types in different populations * studying the success of transplantation, cellular therapies or supportive care in the management of marrow toxic injuries * performing de-linked (anonymous) research

Key Dates

Start date
Jul 31, 1991
Status verified
Mar 2023
Primary completion
Jul 31, 2030
Completion
Jul 31, 2030

Study Design

Enrollment
99,999,999 participants (estimated)

Primary Outcome Measure

To make blood samples available for research studies related to histocompatibility and HCT or other cellular therapy [ Time Frame: pre-HCT (recipient) or pre-donation (donor) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NMDP BiorepositoryNew BrightonMinnesota55112
Liz Weideman
651-745-5036

Find similar trials in New Brighton, MN

Related Studies